Section Arrow
AIDX.NASDAQ
- 20/20 Biolabs, Inc.
Quotes are at least 15-min delayed:2026/04/26 01:54 EDT
Regular Hours
Last
 1.64
+0.02 (+1.23%)
Day High 
1.71 
Prev. Close
1.62 
1-M High
2.08 
Volume 
52.39K 
Bid
1.6
Ask
1.68
Day Low
1.58 
Open
1.64 
1-M Low
1.5 
Market Cap 
16.98M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.75 
20-SMA 1.81 
50-SMA -- 
52-W High 50 
52-W Low 1.5 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.36/--
Enterprise Value
18.09M
Balance Sheet
Book Value Per Share
-0.01
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
2.05M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ITOCiTonic Holdings Ltd.0.374+0.0744+24.83%-- 
BSXBoston Scientific Corp62.07-3.62-5.51%33.94PE
ABTAbbott Laboratories91.13-1.35-1.46%24.75PE
EWEdwards Lifesciences Corp84.15+4.43+5.56%45.45PE
PACBPacific Biosciences of California1.56-0.01-0.64%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity thatconsists of inflammatory biomarkers.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.